Integrating tumor microenvironment with cancer molecular classifications

被引：0
作者：
Etienne Becht
Aurélien de Reyniès
Wolf H. Fridman
机构：
[1] INSERM UMR_S 1138,
[2] Cancer,undefined
[3] Immune Control and Escape,undefined
[4] Cordeliers Research Centre,undefined
[5] Université Paris Descartes,undefined
[6] Université Pierre et Marie Curie,undefined
[7] Programme Cartes d’Identité des Tumeurs,undefined
[8] Ligue Nationale Contre le Cancer,undefined
来源：
Genome Medicine | / 7卷
关键词：
Immune Checkpoint; Checkpoint Inhibitor; Molecular Subgroup; Immune Microenvironment; Suppressive Myeloid Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The composition of the tumor microenvironment is associated with a patient's prognosis and can be therapeutically targeted. A link between the cellular composition and genomic features of the tumor and its response to immunotherapy is beginning to emerge. Analyzing the microenvironment of tumor molecular subgroups can be a useful approach to tailor immunotherapies.
引用
收藏
相关论文
共 56 条
[1]  
Fridman WH(2012)The immune contexture in human tumours: impact on clinical outcome Nat Rev Cancer 12 298-306
[2]  
Pagès F(2006)Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs Immunity 25 643-54
[3]  
Sautès-Fridman C(2012)Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 366 2455-65
[4]  
Galon J(2008)Cancer-related inflammation Nature 454 436-44
[5]  
Moyron-Quiroz JE(2013)Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin Clin Cancer Res 19 4079-91
[6]  
Rangel-Moreno J(2015)Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting Clin Cancer Res 21 1329-39
[7]  
Hartson L(2015)Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC) Oncoimmunology 372 2509-20
[8]  
Kusser K(2015)The consensus molecular subtypes of colorectal cancer Nat Med 348 124-8
[9]  
Tighe MP(2015)PD-1 Blockade in tumors with mismatch-repair deficiency N Engl J Med undefined undefined-undefined
[10]  
Klonowski KD(2015)Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer Science undefined undefined-undefined
123456